We are live on ! Find out more
AH

Andreas Halvorsen Viking Global Investors

AUM $35.1B
1-Year Est. Return 21.36%
 

Andreas Halvorsen is the founder of Viking Global Investors, another prominent firm with roots in Julian Robertson’s Tiger Management. Viking is known for fundamental long/short equity investing and a large, research-intensive platform. Its public filings are widely monitored for institutional-quality growth and cyclical equity ideas.

This Fund
S&P 500
This Quarter Est. Return
-3.96%
1 Year Est. Return
+21.36%
3 Year Est. Return
+97.07%
5 Year Est. Return
+98.11%
10 Year Est. Return
+504%
AUM
$35.7B
AUM Growth
-$1.93B
Cap. Flow
+$296M
Cap. Flow %
0.83%
Top 10 Hldgs %
34.91%
Holding
95
New
19
Increased
25
Reduced
22
Closed
18

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$935M
2
V icon
Visa
V
+$754M
3
META icon
Meta Platforms (Facebook)
META
+$681M
4
FDX icon
FedEx
FDX
+$671M
5
CVNA icon
Carvana
CVNA
+$638M

Sector Composition

Rank Sector Weight
1 Financials 21.33%
2 Consumer Discretionary 16.44%
3 Healthcare 14.66%
4 Technology 14.65%
5 Industrials 13.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBOE icon
51
Cboe Global Markets
CBOE
$31.4B
$193M 0.54%
+688,417
New +$192M
ROIV icon
52
Roivant Sciences
ROIV
$26.2B
$184M 0.52%
6,652,448
+209,257
+3% +$5.38M
HD icon
53
Home Depot
HD
$335B
$166M 0.46%
+504,257
New +$184M
AJG icon
54
Arthur J. Gallagher & Co
AJG
$67.6B
$158M 0.44%
727,441
-313,536
-30% -$72.4M
LULU icon
55
lululemon athletica
LULU
$13.7B
$150M 0.42%
+980,568
New +$176M
NAMS icon
56
NewAmsterdam Pharma
NAMS
$3.33B
$135M 0.38%
4,203,567
ORKA
57
Oruka Therapeutics
ORKA
$7.15B
$131M 0.37%
2,666,690
SION
58
Sionna Therapeutics
SION
$239M
$128M 0.36%
3,195,181
STLA icon
59
Stellantis
STLA
$20.4B
$112M 0.31%
15,980,268
-23,082,283
-59% -$193M
CRWV
60
CoreWeave
CRWV
$48.5B
$108M 0.3%
+1,397,438
New +$121M
MANE
61
Veradermics Inc
MANE
$4.3B
$107M 0.3%
+1,690,555
New +$85.3M
WST icon
62
West Pharmaceutical
WST
$24.8B
$105M 0.29%
416,948
+121,920
+41% +$30.3M
PHVS icon
63
Pharvaris
PHVS
$2.55B
$103M 0.29%
3,653,310
INBX icon
64
Inhibrx
INBX
$1.53B
$96.7M 0.27%
1,437,705
IBKR icon
65
Interactive Brokers
IBKR
$42.5B
$93.5M 0.26%
+1,394,329
New +$99.5M
RAL
66
Ralliant Corp
RAL
$7.04B
$88.8M 0.25%
2,134,899
-1,027,731
-32% -$48.3M
EW icon
67
Edwards Lifesciences
EW
$51.8B
$87.9M 0.25%
+1,097,578
New +$90.5M
ORIC icon
68
Oric Pharmaceuticals
ORIC
$1.47B
$73.8M 0.21%
5,824,533
-748,158
-11% -$8.49M
DMRA
69
Damora Therapeutics
DMRA
$1.9B
$59.9M 0.17%
+2,311,082
New +$59.4M
TWLO icon
70
Twilio
TWLO
$34.6B
$56.7M 0.16%
+450,770
New +$55.4M
LAB icon
71
Standard BioTools
LAB
$263M
$53.9M 0.15%
58,651,170
TRVI icon
72
Trevi Therapeutics
TRVI
$2.56B
$38.2M 0.11%
3,198,644
DNA icon
73
Ginkgo Bioworks
DNA
$498M
$21.9M 0.06%
3,577,128
EQPT
74
EquipmentShare.com Inc
EQPT
$4.69B
$20.4M 0.06%
+1,000,000
New +$28.6M
FPS
75
Forgent Power Solutions
FPS
$8.63B
$19M 0.05%
+650,000
New +$21.6M

Similar funds

Andreas Halvorsen's Q1 2026 Portfolio in Review

As of Q1 2026, Andreas Halvorsen held 95 positions worth $35.7B, down 5.1% from $37.7B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Andreas Halvorsen's Q1 2026 filing shows 19 new, 25 increased, 22 reduced and 18 closed positions. Its largest new stake was Apple: 3,593,057 shares worth $912M. The largest sale was PNC Financial Services, an estimated $927M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Andreas Halvorsen's largest Q1 2026 buy was Apple: 3,593,057 shares worth $912M.
  • Andreas Halvorsen added most to Visa in Q1 2026, an estimated $754M increase.
  • Andreas Halvorsen's biggest Q1 2026 reduction was PNC Financial Services, cutting an estimated $927M.
  • Andreas Halvorsen fully exited Advanced Micro Devices in Q1 2026, selling an estimated $801M.
  • Andreas Halvorsen's ten largest holdings make up 35% of its $35.7B portfolio in Q1 2026.
  • Andreas Halvorsen opened 19 new positions and closed 18 in Q1 2026.
  • Andreas Halvorsen's portfolio value fell 5.1% quarter-over-quarter to $35.7B.

Based on Viking Global Investors's 13F filing for Q1 2026, filed 15 May 2026.